BTI
FLGT icon

Blue Trust Inc’s Fulgent Genetics FLGT Stock Holding History

Blue Trust Inc’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29K Hold
63
– – ﹤0.01% 2256
2026
Q1 		$1K Buy
+63
New +$1.37K ﹤0.01% 2260
2025
Q4 		– Sell
-12
Closed -$271 – 2596
2025
Q3 		$271 Hold
12
– – ﹤0.01% 2494
2025
Q2 		$239 Hold
12
– – ﹤0.01% 2373
2025
Q1 		$203 Hold
12
– – ﹤0.01% 2420
2024
Q4 		$222 Sell
12
-85
-88% -$1.66K ﹤0.01% 2380
2024
Q3 		$1.9K Sell
97
-179
-65% -$4K ﹤0.01% 2591
2024
Q2 		$5.99K Buy
+276
New +$5.76K ﹤0.01% 2128
2024
Q1 		– Sell
-82
Closed -$2K – 2368
2023
Q4 		$2K Buy
+82
New +$2.19K ﹤0.01% 2137
2023
Q2 		– Sell
-236
Closed -$7K – 2185
2023
Q1 		$7K Sell
236
-94
-28% -$3.02K ﹤0.01% 1688
2022
Q4 		$12K Sell
330
-277
-46% -$9.91K ﹤0.01% 1471
2022
Q3 		$33K Buy
607
+557
+1,114% +$27.9K ﹤0.01% 899
2022
Q2 		$3K Buy
+50
New +$2.75K ﹤0.01% 1568

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Blue Trust Inc's FLGT Position: Q2 2026 in Review

Blue Trust Inc held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 63 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Blue Trust Inc first reported a position in FLGT in Q2 2022 and has held it in 13 quarters since. The position peaked at $33K in Q3 2022. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Blue Trust Inc held 63 shares of Fulgent Genetics worth $1.29K as of Q2 2026.
  • Blue Trust Inc left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2256 holding.
  • Blue Trust Inc first reported a position in Fulgent Genetics in Q2 2022 and has held it in 13 quarters since.
  • Blue Trust Inc's Fulgent Genetics position peaked at $33K in Q3 2022.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.